Charles River Laboratories International Inc (CRL)

10:16 AM

U.S. Sterility Testing Market Set to Boom Rapidly by 2033 | Thermo - openPR.com

10:16 AM

08:39 AM

Charles River extends gains as Evercore upgrades after Q1 beat - MSN

08:39 AM

Mar 25, 2026

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch

Mar 25, 2026

Mar 25, 2026

Why is Charles River (CRL) down 6.8% since last earnings report? - MSN

Mar 25, 2026

Mar 25, 2026

Charles River Laboratories stock: Is CRL underperforming the healthcare sector? - MSN

Mar 25, 2026

Mar 25, 2026

Charles River Labs stock faces technical shift to sideways amid mixed signals and 2026 guidance - AD HOC NEWS

Mar 25, 2026

Mar 24, 2026

Charles River Laboratories Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo

Mar 24, 2026

Mar 23, 2026

Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector? - Barchart.com

Mar 23, 2026

Mar 23, 2026

Could Charles River (CRL) Using Locus Cell Tie-Up to Reframe Its Asia-Pacific Growth Strategy? - simplywall.st

Mar 23, 2026

Mar 23, 2026

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MSN

Mar 23, 2026

Mar 22, 2026

10,284 Shares in Charles River Laboratories International, Inc. $CRL Purchased by Oliver Luxxe Assets LLC - MarketBeat

Mar 22, 2026

Mar 21, 2026

JPMorgan Chase & Co. Raises Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 21, 2026

Mar 20, 2026

Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report? - Yahoo Finance

Mar 20, 2026

Mar 20, 2026

Confluence Investment Management LLC Has $21.07 Million Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 20, 2026

Mar 18, 2026

FDA issues guidance on replacing animal testing (CRL:NYSE) - Seeking Alpha

Mar 18, 2026

Mar 17, 2026

Charles River Laboratories International, Inc. (NYSE:CRL) Sees Significant Increase in Short Interest - MarketBeat

Mar 17, 2026

Mar 17, 2026

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Mar 17, 2026

Mar 17, 2026

Charles River Laboratories International (CRL) faces biotech R&D spending headwinds - MSN

Mar 17, 2026

Mar 17, 2026

National Bank of Canada FI Grows Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 17, 2026

Mar 16, 2026

Charles River announces divestitures, updates guidance - MSN

Mar 16, 2026

Mar 16, 2026

Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 16, 2026

Mar 16, 2026

CRL,PBE Volatility & Greeks - Finviz

Mar 16, 2026

Mar 16, 2026

Charles River Laboratories International, Inc. $CRL Holdings Reduced by Iron Triangle Partners LP - MarketBeat

Mar 16, 2026

Mar 16, 2026

Gotham Asset Management LLC Acquires 46,594 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 16, 2026

Mar 15, 2026

Charles River Laboratories International, Inc. Common Stock (NY: CRL - The Chronicle-Journal

Mar 15, 2026

Mar 15, 2026

Charles River Laboratories Hits Day Low of $151.91 Amid Price Pressure - Markets Mojo

Mar 15, 2026

Mar 15, 2026

Earnest Partners LLC Raises Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 15, 2026

Mar 15, 2026

Algert Global LLC Buys 39,586 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 15, 2026

Mar 14, 2026

Charles River Laboratories Stock (ISIN: US1591881009) Surges on Earnings Beat and $1B Buyback Amid R - AD HOC NEWS

Mar 14, 2026

Mar 14, 2026

A Look At Charles River Laboratories (CRL) Valuation After Its Earnings Beat And New US$1b Buyback - simplywall.st

Mar 14, 2026

Mar 14, 2026

Are Charles River’s New Advanced Therapy Deals Quietly Rewriting Its Drug-Development Moat Story (CRL)? - Sahm

Mar 14, 2026

Mar 14, 2026

Charles River announces strategic review including 'examination of various alternatives' - MSN

Mar 14, 2026

Mar 14, 2026

Charles River Laboratories International, Inc. $CRL Position Lessened by Integral Health Asset Management LLC - MarketBeat

Mar 14, 2026

Mar 14, 2026

Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 14, 2026

Mar 13, 2026

Meridiem Capital Partners LP Sells 49,567 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 13, 2026

Mar 13, 2026

Zacks Research Issues Negative Outlook for CRL Earnings - MarketBeat

Mar 13, 2026

Mar 13, 2026

Connor Clark & Lunn Investment Management Ltd. Has $28.25 Million Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 13, 2026